ID   OHK [Human primary effusion lymphoma]
AC   CVCL_W730
DR   Wikidata; Q54931892
RX   PubMed=11841405;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=11841405).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=11841405; DOI=10.1046/j.1365-2141.2002.03244.x;
RA   Kuwabara, Hiroko
RA   Nagai, Masami
RA   Kawakami, Kimihiro
RA   Ohmori, Minoru
RA   Tasaka, Taizo
RA   Funamoto, Yasunobu
RA   Yamaoka, Genji
RA   Nishio, Hajime
RA   Suzuki, Koichi
RA   Mori, Hiroshi
RT   "Establishment and characterization of a Kaposi's sarcoma-associated
RT   herpesvirus- and Epstein-Barr virus-negative malignant lymphoma cell
RT   line (OHK) with primary effusion lymphoma immunophenotype.";
RL   Br. J. Haematol. 116:128-134(2002).
//